↓ Skip to main content

Dove Medical Press

A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician’s Choice in a New Therapeutic Scenario

Overview of attention for article published in Journal of Hepatocellular Carcinoma, April 2021
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#40 of 253)
  • Above-average Attention Score compared to outputs of the same age (59th percentile)
  • Good Attention Score compared to outputs of the same age and source (73rd percentile)

Mentioned by

twitter
5 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
40 Mendeley